st.Jude hospital team injected genetically modified BMC's into the laboratory model, resulting monocytes migrated to the degenerated brain cells that lack the gene for beta-galactosidase

http://www.eurekalert.org/pub_releases/2005-06/sjcr-gmc062205.php